Arr, the Biden crew be beggin' the Supreme Court to tackle a mighty abortion pill matter, mateys!
2023-09-09
Arr, ye scurvy dogs of the Justice Department be pleadin' with the Supreme Court to take a gander at a ruling that bein' restrictin' the use o' the abortion pill mifepristone! They be callin' it a decision without precedent! Walk the plank, I say!
The Biden administration has asked the Supreme Court to review a lower court opinion that placed restrictions on the distribution of the abortion pill, mifepristone. In a cert petition, the Justice Department argued that the loss of access to the drug would be damaging for women and healthcare providers. They emphasized that mifepristone is the best method to terminate early pregnancies and that the FDA has determined it to be safe and effective. The government criticized the lower court's decision, stating that it would force the FDA to return to unnecessary and unjustified restrictions on distribution. The abortion pill manufacturer, Danco Laboratories, also filed its own petition seeking Supreme Court review of the ruling. Last month, the 5th U.S. Circuit Court of Appeals rolled back FDA deregulation of the abortion pill, ending its availability by mail and limiting its use to the seventh week of pregnancy instead of the previous 10 weeks. The Justice Department called this decision unprecedented and contradictory to the FDA's expert judgment. However, the Supreme Court has issued a temporary injunction keeping the Biden administration's deregulated rules in place while the case proceeds through court. Mifepristone remains available in states where abortion is legal under FDA-approved conditions. The pill, known as Mifeprex, is taken in a two-drug regimen to terminate early pregnancy. It has been used by over 5 million women in the United States since its approval in 2000. The drug is 97% effective, although a small percentage of women may require surgical intervention. The FDA's approval of mifepristone has been challenged by Alliance Defending Freedom, which celebrated the 5th Circuit's decision as a victory for women's health.